Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional Shares 31-05-2024, 13:00

Alvotech and Teva Announce U.S. FDA Approval of Additional Presentation of SELARSDI™ (ustekinumab-aekn), Expanding its Label to Include Further Indications Approved for Reference Product, Stelara® (ustekinumab) 22-10-2024, 18:00

GigaDevice to Showcase Comprehensive Industry Solutions at 13-03-2023, 13:03